Stockreport

Oragenics, Inc. Receives Audit Opinion with Going Concern Explanation [Yahoo! Finance]

Oragenics Inc.  (OGEN) 
NASDAQ:AMEX Investor Relations: ir.oragenics.com
PDF American: OGEN), a clinical-stage biotechnology company pioneering brain-targeted therapeutics through proprietary intranasal delivery technology, announced that, as pre [Read more]